NUBEQA

Identification of Nubeqa

No description

Google image searchProduct monograph

Active ingredient

darolutamide, 300 MG

DIN: 02496348

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: BAYER INC

Date: 24-MAR-2020

ATC:

• L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
• L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
• L02BB — Anti-androgens (ATC, ATC/DDD)
• L02BB06 — DAROLUTAMIDE (ATC/DDD)

External Links for Nubeqa

Search on Google

• Nubeqa side effects
• Nubeqa dosage
• darolutamide side effects
• darolutamide dosage

Bayer Inc

Go to Bayer website to see drug product details. Sometimes you can find nubeqa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.